Glymidine sodium
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | A10BC01 (WHO) |
Pharmacokinetic data | |
Bioavailability | High |
Protein binding | 90% |
Biological half-life | 3.8 hours |
Identifiers | |
| |
CAS Number | 339-44-6 |
PubChem (CID) | 9565 |
DrugBank | DB01382 |
ChemSpider | 9190 |
UNII | 4C5I4BQZ8F |
ChEMBL | CHEMBL1697838 |
ECHA InfoCard | 100.005.842 |
Chemical and physical data | |
Formula | C13H15N3O4S |
Molar mass | 309.34 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Glymidine sodium (INN, also known as glycodiazine; trade name Gondafon) is a sulfonamide antidiabetic drug, structurally related to the sulfonylureas. It was first reported in 1964, and introduced to clinical use in Europe in the mid to late 1960s.[1]
References
- ↑ [No authors listed] (June 1967). "Glymidine". Br Med J. 2 (5555): 817. doi:10.1136/bmj.2.5555.817. PMC 1843097. PMID 6029147.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.